v3.26.1
Condensed Statement of Cash Flows - USD ($)
 5 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (39,474) $ 4,035,451
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (96,478) (4,838,462)
Change in Fair Value of Overallotment liability (10,666) 446
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (228,774) 124,779
Accounts payable and accrued expenses 41,117 90,505
Net cash used in operating activities (334,275) (587,281)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (100,500,000) (15,075,000)
Net cash used in investing activities (100,500,000) (15,075,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 98,125,000 14,718,750
Proceeds from sale of Private Placement Units 4,000,000 375,000
Proceeds from share subscription receivable from shareholder 25,000 0
Proceeds from issuance of representative shares 2,319 0
Proceeds from promissory note – related party 322,720 0
Repayment of promissory note—related party (322,720) 0
Payment of offering costs (436,191) 0
Net cash provided by financing activities 101,716,128 15,093,750
Net Change in Cash 881,853 (568,531)
Cash – Beginning of period 0 881,853
Cash – End of period 881,853 313,322
Non-Cash investing and financing activities:    
Remeasurement of carrying value to redemption value 5,918,545 5,397,684
Deferred offering costs included in accrued offering costs 75,000 0
Deferred offering costs paid by Sponsor in exchange for issuance of non-redeemable ordinary shares $ 383 $ 0